This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2fo4
From Proteopedia
OCA (Talk | contribs)
(New page: 200px<br /> <applet load="2fo4" size="450" color="white" frame="true" align="right" spinBox="true" caption="2fo4, resolution 2.70Å" /> '''Enhanced MHC class ...)
Next diff →
Revision as of 20:01, 12 November 2007
|
Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical tumor associated MUC1-8 peptide
Overview
Designing peptide-based vaccines for therapeutic applications in cancer, immunotherapy requires detailed knowledge of the interactions between the, antigenic peptide and major histocompatibility complex (MHC) in addition, to that between the peptide-MHC complex and the T-cell receptor. Past, efforts to immunize with high-affinity tumour-associated antigenic, peptides have not been very immunogenic, which may be attributed to the, lack of T cells to these peptides, having been deleted during thymic, development. For this reason, low-to-medium affinity non-canonical, peptides represent more suitable candidates. However, in addition to the, difficulty in identifying such antigens, peptide binding to MHC, and hence, its ability to induce a strong immune response, is limited. Therefore, to, enhance binding to MHC and improve immune responses, anchor modifications, of non-canonical tumour-associated peptides would be advantageous. In this, study, the non-canonical tumour-associated peptide from MUC1, MUC1-8, (SAPDTRPA), was modified at the MHC anchor residues to SAPDFRPL, (MUC1-8-5F8L) and showed enhanced binding to H-2Kb and improved immune, responses. Furthermore, the crystal structure of MUC1-8-5F8L in complex, with H-2Kb was determined and it revealed that binding of the peptide to, MHC is similar to that of the canonical peptide OVA8 (SIINFEKL).
About this Structure
2FO4 is a Protein complex structure of sequences from Mus musculus with NAG, PO4 and MPD as ligands. Full crystallographic information is available from OCA.
Reference
Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide., Lazoura E, Lodding J, Farrugia W, Ramsland PA, Stevens J, Wilson IA, Pietersz GA, Apostolopoulos V, Immunology. 2006 Nov;119(3):306-16. PMID:17067310
Page seeded by OCA on Mon Nov 12 22:08:20 2007
Categories: Mus musculus | Protein complex | Lazoura, E. | Ramsland, P.A. | MPD | NAG | PO4 | Anchor modifications | H-2kb | Muc1 | Muc1-8 | Non-canonical peptide | Vaccine design
